BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3509461)

  • 1. Aztreonam in gram-negative infections in children.
    Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G
    Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
    LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
    Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficiency and possibility of the use of aztreonam in bacterial infections caused by gram-negative organisms].
    Caramia G; Compagnoni L; Pettinari A; Gregorini S
    Minerva Pediatr; 1986 Sep; 38(17-18):773-7. PubMed ID: 3796535
    [No Abstract]   [Full Text] [Related]  

  • 4. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of aztreonam in pediatric patients: a review.
    Bosso JA; Black PG
    Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam in the treatment of serious gram-negative infections in the elderly.
    Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aztreonam: the first monobactam antibiotic.
    Stutman HR
    Pediatr Infect Dis J; 1987 Jun; 6(6):550-5. PubMed ID: 3302907
    [No Abstract]   [Full Text] [Related]  

  • 8. Aztreonam therapy for serious gram-negative bacillary infections.
    Cone LA; Woodard DR
    Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aztreonam for severe infections.
    Wood MJ; Smith G; Farrell ID
    Chemioterapia; 1987 Jun; 6(2 Suppl):384-5. PubMed ID: 3509453
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
    Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
    Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH; McCracken GH
    Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aztreonam in children with severe infections of the urinary tract].
    Rancilio L; Assael BM; Boccazzi A; Colombo R; Crossignani R; Garlaschi L; Rusconi F
    G Ital Chemioter; 1985; 32(2):437-41. PubMed ID: 3833586
    [No Abstract]   [Full Text] [Related]  

  • 13. Employment of azthreonam in generalized and localized infections determined by gram negative bacteria.
    Terragna A; Giacchino R; Viscoli C; Consani G
    G Ital Chemioter; 1985; 32(2):423-5. PubMed ID: 3833582
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
    Raz R; Flatau E; Sudarsky M; Keness J
    Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aztreonam in the therapy of severe gram-negative infections.
    Davies A; Stone J; Hassan A; Quarty P; Green T
    Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract]   [Full Text] [Related]  

  • 16. Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.
    Feris J; Moledina N; Rodriguez WJ; Khan WN; Puig J; Wiedermann BL; Ahmad S
    Chemotherapy; 1989; 35 Suppl 1():31-8. PubMed ID: 2731448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aztreonam in lower respiratory tract infections.
    Cook JL
    Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aztreonam: new developments in the treatment of gram-negative infections in children. Chicago, Illinois, November 17, 1988. Proceedings.
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S99-132. PubMed ID: 2812921
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E; Bosch-Perez A
    Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy of aztreonam in refractory infections in children].
    Ogura H; Hamada F; Fujieda M; Matsumoto K; Araki K; Ogura Y; Kuramitsu M; Kurashige T; Kitamura I
    Jpn J Antibiot; 1985 Nov; 38(11):3349-57. PubMed ID: 4094068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.